

Novozymes South Asia Profile
Key Indicators
- Authorised Capital ₹ 110.00 Cr
- Paid Up Capital ₹ 106.00 Cr
- Company Age 26 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 14.15%
- Profit Growth 26.51%
- Ebitda 14.11%
- Net Worth 11.21%
- Total Assets 6.63%
About Novozymes South Asia
Novozymes South Asia Private Limited (NSAPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 August 1998 and has a history of 26 years and seven months. Its registered office is in Bangaluru, Karnataka, India.
The Corporate was formerly known as Novo Nordisk Enzymes Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 110.00 Cr and a paid-up capital of Rs 106.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Novozymes South Asia Private Limited India is Sumedha Hegde as COMPANY SECRETARY. Mikkel Viltoft, Manish Mittal, and Krishnamohan Puvvada serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24299KA1998PTC024038
- Company No.
024038
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Aug 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
What products or services does Novozymes South Asia Private Limited offer?
Novozymes South Asia Private Limited offers a wide range of products and services, including Cleaning Liquids & Wipes, Toilet Cleaners, Cookware and Cooking Utensils, Cooking Range, PVC, CPVC, HDPE Water Pipe Fittings, Plastic Pipe Fittings, Cleaning Chemicals, Water Treatment & Purification Plant, Sewage Treatment Plants, Extraction Plants and Extruders.
Who are the key members and board of directors at Novozymes South Asia?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sumedha Hegde ![]() | Company Secretary | 03-Apr-2018 | Current |
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Manish Mittal ![]() | Whole-Time Director | 01-Aug-2016 | Current |
Mikkel Viltoft ![]() | Director | 09-Sep-2009 | Current |
Krishnamohan Puvvada ![]() | Whole-Time Director | 26-Aug-2019 | Current |
Financial Performance of Novozymes South Asia.
Novozymes South Asia Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.15% increase. The company also saw a substantial improvement in profitability, with a 26.51% increase in profit. The company's net worth Soared by an impressive increase of 11.21%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Novozymes South Asia?
In 2023, Novozymes South Asia had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Uas Life Sciences India Private Limited
Krishnamohan Puvvada is a mutual person
- Synergia Life Sciences Private Limited
Manish Mittal and Krishnamohan Puvvada are mutual person
- Riata Life Sciences Private Limited
Manish Mittal and Krishnamohan Puvvada are mutual person
Charges (Loans)

There are no open charges registered against the company as per our records.
How Many Employees Work at Novozymes South Asia?
Novozymes South Asia has a workforce of 542 employees as of Oct 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Novozymes South Asia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novozymes South Asia's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Novozymes South Asia
Recent activity within the organization
- Annual General Meeting
Novozymes South Asia Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Novozymes South Asia Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
- Director Appointment
Krishnamohan Puvvada was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 26 Aug 2019 & has been associated with this company since 5 years 7 months .
- Director Appointment
Sumedha Gajanan Hegde was appointed as a Company Secretary was appointed as a Company Secretary on 03 Apr 2018 & has been associated with this company since 6 years 11 months .
- Director Appointment
Manish Kumar Mittal was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 01 Aug 2016 & has been associated with this company since 8 years 7 months .
- Director Appointment
Mikkel Viltoft was appointed as a Director was appointed as a Director on 09 Sep 2009 & has been associated with this company since 15 years 6 months .
Recent News, Updates & Announcement
Frequently asked questions
What is the Incorporation or founding date of Novozymes South Asia Private Limited?
Novozymes South Asia Private Limited was incorporated on 04 Aug 1998.
What is authorized share capital and paid-up capital of Novozymes South Asia Private Limited?
The authorized share capital of Novozymes South Asia Private Limited is ₹ 110.00 Cr and paid-up capital is ₹ 106.00 Cr.
Who are the current board members & directors of Novozymes South Asia Private Limited?
Currently 4 directors are associated with Novozymes South Asia Private Limited.
- Mikkel Viltoft
- Manish Kumar Mittal
- Sumedha Gajanan Hegde
- Krishnamohan Puvvada
What is the registered address of Novozymes South Asia Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Novozymes South Asia Private Limited is Plot No.32 47-50 Epip Area, Whitefield India, Bangalore, Karnataka, 560066.
What is the corporate identification number (CIN) and company number of Novozymes South Asia Private Limited?
The corporate identification number (CIN) of Novozymes South Asia Private Limited is U24299KA1998PTC024038 and the company number is 024038 as per Ministry of Corporate Affairs (MCA).
What is the official website of Novozymes South Asia Private Limited?
The Official website of Novozymes South Asia Private Limited is https://www.novozymes.com
What has been the recent revenue trend for Novozymes South Asia Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Novozymes South Asia Private Limited has risen by 14.15%.
How many employees does Novozymes South Asia Private Limited currently have?
As Per 2023 financial reports, 542 employees are currently employed by Novozymes South Asia Private Limited.
What change has been observed in the net worth of Novozymes South Asia Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Novozymes South Asia Private Limited has experienced an upsurge of 11.21%.
When was the last Balance Sheet of Novozymes South Asia Private Limited filed with the ROC?
The most recent Balance Sheet for Novozymes South Asia Private Limited was filed with the ROC on 31 Mar 2023.
People also Viewed
GK
Gobichettipalayam KrishnanManaging DirectorKM
Kristian MerserDirectorMB
Mads BodenhoffDirectorTV
Thomas VidebaekDirectorMP
Maarit PokkinenAdditional DirectorPN
Peder NielsenDirectorUS
Uno SteffensenDirectorLG
Lars GreenDirector